Summary of results for the current study
| Mean±SD | Range | |
| Eyes (n) | 21 | – |
| Male | 13 | – |
| Female | 8 | – |
| Age (years) | 73.3±11.1 | 45–91 |
| Time to treat (hours) | 54.7±76.3 | 2–240 |
| BCVA (LogMAR) | ||
| First visit | 2.18±0.60 | 0.82–2.8 |
| 1 month | *1.54±0.84 | 0–2.5 |
| 3 months | *1.53±0.88 | 0–2.8 |
| CRT (μm) | ||
| First visit | 221±66 | 130–444 |
| 1 month | *184±30 | 136–241 |
| 3 months | *169±21 | 123–207 |
| OIR | ||
| First visit | 1.09±0.22 | 0.68–1.54 |
| 1 month | *0.84±0.17 | 0.61–1.27 |
| 3 months | *0.68±0.11 | 0.61–0.91 |
| A/D (%) | ||
| First visit | 0.034±0.0095 | 0.021–0.054 |
| 1 month | 0.035±0.010 | 0.020–0.051 |
| V/D (%) | ||
| First visit | 0.040±0.013 | 0.012–0.068 |
| 1 month | *0.052±0.016 | 0.025–0.076 |
*Significantly different from the first visit (p<0.05)
A/D, ratio of retinal artery diameter to optic disc diameter; BCVA, best-corrected visual acuity; CRT, central retinal thickness; LogMAR, logarithm of the minimal angle of resolution; OIR, optical intensity ratio; V/D, ratio of retinal vein diameter to optic disc diameter.